Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins - A long-term cohort study
P. Lind et al., Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins - A long-term cohort study, ART THROM V, 21(3), 2001, pp. 452-458
Inflammation may play an important role in atherosclerotic disease. Plasma
fibrinogen is an established predictor of cardiovascular events. The aim of
this study was to evaluate whether other inflammation-sensitive plasma pro
teins modify this prediction. We studied the incidence of cardiac events an
d death in men in relation to fibrinogen levels alone and in combination wi
th other proteins. The study was based on 6075 men, who were, on average, 4
6 years old at the time of the screening examination, which included the qu
antitative assessment of plasma levels of fibrinogen, orosomucoid, alpha (1
)-antitrypsin, haptoglobin, and ceruloplasmin. The concentration of each pr
otein was divided into quartiles for each. This classification made it poss
ible to identify 4 groups, ie, men in the first fibrinogen quartile and at
the same time either not belonging to the fourth quartile of any of the oth
er proteins (Q1/No group) or also belonging to the fourth quartile of great
er than or equal to1 of the additional proteins (Q1/Yes group) and correspo
nding groups in the fourth fibrinogen quartile (Q4/No and Q4/Yes groups). D
uring the follow-up, which occurred at an average of 16 years, 439 (7.2%) m
en experienced a cardiac event, and 653 (10.7%) died; 278 of these men died
of cardiovascular diseases, with 206 deaths attributed to ischemic heart d
isease. From the lowest to the highest quartile, there was for each protein
a stepwise increase in the incidence of cardiac events and mortality. All-
cause mortality and cardiovascular mortality were significantly higher in t
he Q4/Yes group compared with the Q4/No group, but they were similar in the
Q4/No and Q1/Yes groups. The incidence of cardiac events was significantly
higher in the Q1/Yes and Q4/Yes groups compared with the Q1/No and Q4/No g
roups, respectively. The increased cardiovascular mortality and cardiac eve
nt rates remained after adjustment for several confounders when the Q4/Yes
and Q4/No groups were compared. The results suggest that the incidence of c
ardiac events and death due to cardiovascular diseases in middle-aged men p
redicted by plasma levels of fibrinogen is modified by other inflammation-s
ensitive proteins.